[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:myeloproliferative-neoplasm":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":210,"states":219},"Myeloproliferative Neoplasm",33,28,[8,16,23,29,34,40,46,52,58,64,70,76,82,88,94,101,107,113,119,125,131,137,143,149,155,160,166,172,178,185,191,197,204],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05025488","Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm",[12],"Phase 1","RECRUITING","2026-08-26T02:15:23.202838Z","2026-05-05T02:43:29.683710Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04493164","CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome",[20],"Phase 2","2026-08-26T02:15:01.639696Z","2026-05-05T02:43:29.153694Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04024761","A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation",[12],"2026-08-26T02:18:54.586325Z","2026-05-05T02:43:29.028485Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":14,"content_modified":33},"NCT04996875","(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis",[20],"2026-05-05T02:43:27.251075Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT07565220","Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies",[12],"2026-08-26T02:16:16.995720Z","2026-05-13T02:55:06.728889Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT04282187","Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated\u002FBlast Phase Myeloproliferative Neoplasms",[20],"2026-08-26T02:17:39.048487Z","2026-05-05T02:43:29.738874Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":50,"content_modified":51},"NCT06859424","A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation",[20],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:28.740200Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":56,"content_modified":57},"NCT04898790","Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant",[],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:28.544550Z",{"nct_id":59,"title":60,"phases":61,"status":13,"updated_at":62,"content_modified":63},"NCT06815003","Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning",[20],"2026-08-26T02:17:36.611194Z","2026-05-05T02:43:28.124047Z",{"nct_id":65,"title":66,"phases":67,"status":13,"updated_at":68,"content_modified":69},"NCT05805605","Allo HSCT Using RIC and PTCy for Hematological Diseases",[20],"2026-08-26T02:17:29.353236Z","2026-05-05T02:43:28.075410Z",{"nct_id":71,"title":72,"phases":73,"status":13,"updated_at":74,"content_modified":75},"NCT04771572","Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS\u002FMPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.",[12],"2026-08-26T02:18:06.247899Z","2026-05-05T02:43:27.598768Z",{"nct_id":77,"title":78,"phases":79,"status":13,"updated_at":80,"content_modified":81},"NCT03630991","Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy",[12],"2026-08-26T02:18:41.390601Z","2026-05-05T02:43:27.485890Z",{"nct_id":83,"title":84,"phases":85,"status":13,"updated_at":86,"content_modified":87},"NCT05884333","Cord Blood Transplant in Adults With Blood Cancers",[20],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:27.262377Z",{"nct_id":89,"title":90,"phases":91,"status":13,"updated_at":92,"content_modified":93},"NCT04644016","Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders",[20],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:27.256850Z",{"nct_id":95,"title":96,"phases":97,"status":13,"updated_at":99,"content_modified":100},"NCT03471260","Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies",[98],"Phase 1\u002FPhase 2","2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.087679Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT03970096","Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)",[20],"2026-08-26T02:17:02.694423Z","2026-05-05T02:43:26.980874Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT06013423","Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases",[20],"2026-08-26T02:16:50.548894Z","2026-05-05T02:43:26.947230Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT06059391","CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant",[20],"2026-08-26T02:16:01.910993Z","2026-05-05T02:35:31.868600Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT07020533","A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant",[12],"2026-08-26T02:18:31.944757Z","2026-05-05T02:43:28.960514Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT06480591","Evaluation of the Pathobiology of CALR-mutated MPN Cells",[],"2026-08-26T02:17:18.747857Z","2026-05-13T02:55:06.494166Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT06131801","Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.418667Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT05556928","Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry",[],"2026-08-26T02:15:00.557154Z","2026-05-13T02:55:06.362539Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT02720679","Investigation of the Genetics of Hematologic Diseases",[],"2026-08-26T02:16:21.385056Z","2026-05-13T02:55:06.100956Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT02402244","Project: Every Child for Younger Patients With Cancer",[],"2026-08-26T02:15:53.461103Z","2026-05-13T02:55:06.094469Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":68,"content_modified":159},"NCT05842603","I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients",[],"2026-05-05T02:43:27.276978Z",{"nct_id":161,"title":162,"phases":163,"status":13,"updated_at":164,"content_modified":165},"NCT06811233","Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study",[20],"2026-08-26T02:19:02.550788Z","2026-05-05T02:43:29.663455Z",{"nct_id":167,"title":168,"phases":169,"status":13,"updated_at":170,"content_modified":171},"NCT05745285","Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care",[],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:27.506943Z",{"nct_id":173,"title":174,"phases":175,"status":13,"updated_at":176,"content_modified":177},"NCT03589729","Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers",[20],"2026-08-26T02:15:34.659160Z","2026-04-29T02:57:57.071823Z",{"nct_id":179,"title":180,"phases":181,"status":182,"updated_at":183,"content_modified":184},"NCT07679334","Phase I Trial of Pacritinib in Combination With Venetoclax and Azacitidine for the Treatment of Accelerated and Blast Phase Myeloproliferative Neoplasms",[12],"NOT_YET_RECRUITING","2026-08-26T02:18:17.007929Z","2026-07-05T03:45:20.440999Z",{"nct_id":186,"title":187,"phases":188,"status":182,"updated_at":189,"content_modified":190},"NCT07572929","A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant",[20],"2026-08-26T02:16:11.347936Z","2026-05-13T02:55:06.778094Z",{"nct_id":192,"title":193,"phases":194,"status":182,"updated_at":195,"content_modified":196},"NCT07634536","Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant",[20],"2026-08-26T02:16:51.982021Z","2026-06-14T18:39:22.254845Z",{"nct_id":198,"title":199,"phases":200,"status":201,"updated_at":202,"content_modified":203},"NCT05732961","Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS\u002FMPN Neoplasms",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T02:59:02.155507Z","2026-05-05T02:43:28.651417Z",{"nct_id":205,"title":206,"phases":207,"status":201,"updated_at":208,"content_modified":209},"NCT03739502","A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant",[20],"2026-08-03T03:35:37.456806Z","2026-05-05T02:43:28.822840Z",[211,215],{"biomarker":212,"count":213,"slug":214},"HLA Complex",5,"hla-complex",{"biomarker":216,"count":217,"slug":218},"BCR\u002FABL1 Fusion Gene",3,"bcr-abl1-fusion-gene",[220,224,228,232,236,240,243,246,250,253,256,259,262,265,268],{"state":221,"count":222,"slug":223},"Texas",11,"texas",{"state":225,"count":226,"slug":227},"Massachusetts",9,"massachusetts",{"state":229,"count":230,"slug":231},"New York",8,"new-york",{"state":233,"count":234,"slug":235},"California",7,"california",{"state":237,"count":238,"slug":239},"Florida",6,"florida",{"state":241,"count":213,"slug":242},"Ohio","ohio",{"state":244,"count":213,"slug":245},"Washington","washington",{"state":247,"count":248,"slug":249},"Alabama",4,"alabama",{"state":251,"count":248,"slug":252},"Georgia","georgia",{"state":254,"count":248,"slug":255},"Illinois","illinois",{"state":257,"count":248,"slug":258},"North Carolina","north-carolina",{"state":260,"count":248,"slug":261},"Pennsylvania","pennsylvania",{"state":263,"count":217,"slug":264},"Oregon","oregon",{"state":266,"count":217,"slug":267},"Utah","utah",{"state":269,"count":217,"slug":270},"Wisconsin","wisconsin"]